查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1665270

同視機市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Synoptophore Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球同視機市場價值為 2.523 億美元，預計將保持穩定成長率，2025 年至 2034 年的年複合成長率(CAGR) 為 5.5%。隨著人們對早期診斷重要性的認知不斷提高，以及非侵入性診斷技術的不斷進步，對同視機的需求日益成長。這些設備正在成為診斷和治療各種視力障礙不可或缺的工具，特別是在兒科和眼科護理中。

同視細胞市場 - IMG1

根據模式，市場主要分為手動和自動同視機，其中手動部分預計仍將是重要的收入來源。到 2034 年，該部分預計將達到 2.148 億美元，複合年成長率為 5%。手動同視機因其價格便宜、可靠、使用方便而受到青睞。這些設備提供了經濟高效的解決方案，特別適合較小的醫療機構或預算有限的地區。其簡單而有效的設計使醫療保健專業人員在視力檢查期間能夠更好地控制，從而使其能夠有效地解決複雜的視力障礙。手動同視機持續受到青睞也因為其操作簡單，不需要高級的技術專長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 2.523億美元
預測值 4.22億美元
複合年成長率 5.5％

就最終用途而言，同視機市場分為醫院、眼科中心和其他醫療機構。 2024 年，醫院以 47% 的主導佔有率引領市場，預計在整個預測期內都將保持這一領先地位。醫院是同視機的主要用戶，因為它們有能力投資最先進的診斷設備並處理大量的患者。這些設施配備了精確診斷和全面治療介入所需的基礎設施，在視力復健中發揮關鍵作用。人們越來越關注提高診斷準確性和患者護理，這推動了醫院眼科部門擴大採用同視機。

在美國，同視機市場在 2024 年的價值為 9,130​​ 萬美元，預計在 2025 年至 2034 年期間的複合年成長率為 5%。此外，包括將數位功能整合到同視機在內的技術進步正在提高診斷的精確度並改善治療效果。這些設備對於早期發現視力矯正問題至關重要，可以及時介入並取得更好的患者治療效果。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 自動化和數位化同視機的進展
      • 增加醫療支出並改善眼科保健基礎設施
      • 弱視、斜視等雙眼視覺障礙的盛行率不斷上升
    • 產業陷阱與挑戰
      • 需要熟練的專業人員有效地操作同視機
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第 5 章：市場估計與預測：按模式，2021 – 2034 年

  • 主要趨勢
  • 手動的
  • 自動的

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 診斷
  • 療法
  • 混合

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 眼科中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • APPASAMY ASSOCIATES
  • DEVINE MEDITECH
  • GEM OPTICAL
  • HAAG-STREIT
  • REDSUN
  • NAUGRA
  • Roslane Meditech
  • Vowish Optical
  • 66 Vision-Tech
  • YTS Pharmaceuticals
簡介目錄
Product Code: 12750

The Global Synoptophore Market was valued at USD 252.3 million in 2024 and is projected to experience a steady growth rate, expanding at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2034. This market growth is largely driven by the increasing prevalence of binocular vision disorders such as amblyopia and strabismus. With rising awareness about the importance of early diagnosis, along with continuous advancements in non-invasive diagnostic technologies, the demand for synoptophores is gaining momentum. These devices are becoming indispensable tools in the diagnosis and treatment of various visual impairments, particularly within pediatric and ophthalmic care.

Synoptophore Market - IMG1

The market is primarily segmented by mode into manual and automatic synoptophores, with the manual segment expected to remain a significant revenue contributor. By 2034, this segment is projected to reach USD 214.8 million, growing at a CAGR of 5%. Manual synoptophores are favored for their affordability, reliability, and ease of use. These devices offer a cost-effective solution, making them particularly suitable for smaller healthcare facilities or regions with budget constraints. Their simple yet efficient design allows healthcare professionals to have greater control during visual examinations, making them highly effective for addressing complex vision disorders. The continued preference for manual synoptophores is also due to their user-friendly operation, which does not require advanced technical expertise.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$252.3 Million
Forecast Value$422 Million
CAGR5.5%

In terms of end use, the synoptophore market is divided into hospitals, ophthalmic centers, and other healthcare facilities. In 2024, hospitals led the market with a dominant share of 47% and are expected to maintain this leading position throughout the forecast period. Hospitals are major users of synoptophores due to their ability to invest in state-of-the-art diagnostic equipment and handle large patient volumes. These facilities are equipped with the infrastructure necessary for precise diagnostics and comprehensive therapeutic interventions, playing a critical role in vision rehabilitation. The growing focus on enhancing diagnostic accuracy and patient care is driving the increased adoption of synoptophores within hospital ophthalmology departments.

In the U.S., the synoptophore market was valued at USD 91.3 million in 2024 and is expected to grow at a CAGR of 5% from 2025 to 2034. Increasing awareness about visual health, coupled with the rising rates of amblyopia and strabismus, is fueling the demand for synoptophores in the region. Moreover, technological advancements, including the integration of digital features into synoptophores, are boosting diagnostic precision and improving treatment outcomes. These devices are crucial for the early identification of vision alignment issues, allowing for timely intervention that leads to better patient outcomes.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Advancements in automated and digital synoptophores
      • 3.2.1.2 Increasing healthcare spending and improved eye care infrastructure
      • 3.2.1.3 Growing prevalence of binocular vision disorders like amblyopia and strabismus
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Need for skilled professionals to operate synoptophores effectively
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Mode, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Manual
  • 5.3 Automatic

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Diagnostics
  • 6.3 Therapeutics
  • 6.4 Hybrid

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ophthalmic centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 APPASAMY ASSOCIATES
  • 9.2 DEVINE MEDITECH
  • 9.3 GEM OPTICAL
  • 9.4 HAAG-STREIT
  • 9.5 REDSUN
  • 9.6 NAUGRA
  • 9.7 Roslane Meditech
  • 9.8 Vowish Optical
  • 9.9 66 Vision-Tech
  • 9.10 YTS Pharmaceuticals